Manhattan Builders’ 5-Year Plan: 33,000 New Rentals and Condos
(Bloomberg) -- There's a surplus of homes in Manhattan, and here come tens of thousands more.
About 33,000 new units for sale or rent are expected within the next five years, with the largest concentrations in the northern and southern parts of the borough, according to an analysis from Marketing Directors, a new-development brokerage.
The trouble is, Manhattan is already flooded with high-end condos and apartments from a post-recession building boom -- a glut that's put a damper on both rents and purchase prices as New Yorkers take their time to shop for the best deals. For developers, the next wave of construction could add to the pressure to find tenants and buyers.
“It's really the top question we get from our developer clients, after ‘How much can we sell this for?' and ‘How fast can we sell it?'” said Joshua Silverbush, director of market insights for the New York-based brokerage. “What else is coming up, and what are we competing against?”
An estimated 1,643 new rentals are expected to reach the market between now and the end of this year. The apartment pipeline will swell to 3,831 in 2021, according to the firm, which tallied both units that have secured and applied for building permits, as well as announced projects for which paperwork hasn't begun.
More new condos are coming too -- more than 2,000 of them in 2019 alone. For projects with detailed sales plans, the average price per unit is $2.7 million, according to Silverbush. That suggests much of upcoming supply is smaller homes, and less focused on grand spaces aimed at ultra-wealthy investors, he said.
To contact the reporter on this story: Oshrat Carmiel in New York at ocarmiel1@bloomberg.net
To contact the editors responsible for this story: Debarati Roy at droy5@bloomberg.net, Christine Maurus
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.